Joben Bio-Medical Co Ltd is a Taiwan-based company mainly engaged in the development and sale of new plant medicines, local Chinese herbal medicines, health foods and medical beauty products. The Company develops JBM-TC4 plant new drug, which has been patented, used to provide raw materials for cancer treatment drugs.

Employees

Sector

Biotechnology & Medical Research

More about the company

End-of-day quote Taipei Exchange 18/10/2019			5-day change	1st Jan Change
10.50 ^TWD	+0.96%		+8.81%	-

14/19/14	Joben Bio-Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019	CI
15/19/15	Joben Bio-Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018	CI

Market Cap	64Cr 2.03TCr 55Cr 52Cr 47Cr 89Cr 6.05TCr 89Cr 613Cr 237.87Cr 3.1TCr 240.61Cr 235.36Cr 10TCr	P/E 2017	53.5x	P/E 2018	-22.8x
Enterprise Value	87Cr 2.74TCr 75Cr 70Cr 64Cr 120.02Cr 8.19TCr 120.35Cr 829.92Cr 322.04Cr 4.2TCr 325.75Cr 318.64Cr 14TCr	EV / Sales 2017	5.87x	EV / Sales 2018	15.8x
Free-Float	82.63%	Yield 2017	0.07%	Yield 2018	-

14/19/14	Joben Bio-Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019	CI
15/19/15	Joben Bio-Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018	CI

Director	Title	Age	Since
Wen Tien Huang CHM	Chairman	-	20/05/2010
Man Hsia Chia BRD	Director/Board Member	-	20/05/2010
Chao Yuan Kuo BRD	Director/Board Member	-	24/06/2011

JBM Share Price

Stocks

4193

TW0004193008

Biotechnology & Medical Research

Valuation : JBM

Latest news : JBM

Quotes and Performance

Managers and Directors : JBM

Other Biotechnology & Medical Research

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
JBM	+0.96%	+8.81%	-	-	2.1Cr
LONZA GROUP AG	-2.54%	-3.60%	-0.60%	+15.17%	5.03TCr
REVOLUTION MEDICINES, INC.	-0.40%	+1.03%	+439.20%	+523.39%	4.52TCr
IQVIA HOLDINGS INC.	-1.42%	+2.30%	+45.46%	+21.22%	4.47TCr
BEONE MEDICINES AG	-1.22%	-2.31%	+12.40%	+74.90%	4.12TCr
CELLTRION, INC.	+0.53%	-1.67%	+15.16%	+49.88%	3.31TCr
ASCENDIS PHARMA A/S	-0.21%	+9.14%	-	-	1.78TCr
MEDPACE HOLDINGS, INC.	-0.35%	-1.56%	+22.59%	+123.04%	1.66TCr
EUROFINS SCIENTIFIC SE	-1.01%	-0.38%	+15.69%	+28.39%	1.48TCr
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.65%	-1.03%	+77.75%	+41.22%	1.4TCr
Average	-0.94%	+0.89%	+78.46%	+109.65%	2.78TCr
Weighted average by Cap.	-1.38%	-0.46%	+94.49%	+127.49%

	2017	2018
Net sales	55Cr 1.75TCr 48Cr 45Cr 41Cr 77Cr 5.23TCr 77Cr 530.03Cr 205.67Cr 2.68TCr 208.04Cr 203.5Cr 8.65TCr	19Cr 608.74Cr 17Cr 16Cr 14Cr 27Cr 1.82TCr 27Cr 184.08Cr 71Cr 932.06Cr 72Cr 71Cr 3TCr
Net income	6.07Cr 191.91Cr 5.22Cr 4.91Cr 4.49Cr 8.39Cr 572.71Cr 8.42Cr 58Cr 23Cr 293.84Cr 23Cr 22Cr 946.61Cr	-12Cr -390.19Cr -11Cr -9.98Cr -9.12Cr -17Cr -1.16TCr -17Cr -117.99Cr -46Cr -597.42Cr -46Cr -45Cr -1.92TCr
Net Debt	23.49L 7.43Cr 20.21L 19.02L 17.37L 32.5L 22Cr 32.59L 2.25Cr 87.2L 11Cr 88.21L 86.28L 37Cr	23Cr 717.35Cr 20Cr 18Cr 17Cr 31Cr 2.14TCr 31Cr 216.92Cr 84Cr 1.1TCr 85Cr 83Cr 3.54TCr